Biochemical pathways in the antiatherosclerotic effect of berberine

Chinese Medical Journal

Volumn 121, Issue 13, 2008, Pages 1197-1203

  Guo, Yi ^a   Wang, Qi Zhang ^b   Li, Fang Ming ^c   Jiang, Xin ^a   Zuo, Yan Fang ^a   Wang, Ling ^a  

^a JINAN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antiatherosclerotic; Berberine; Cyclooxygenase; erk1 2; jnk; p38mapk

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BERBERINE; CYCLOOXYGENASE 2; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; CYCLOOXYGENASE 2 INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PTGS2 PROTEIN, HUMAN;

ARTICLE; ATHEROSCLEROSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESEARCH; ENZYME ANALYSIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MONOCYTE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; GENETICS; TIME;

ATHEROSCLEROSIS; BERBERINE; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; TIME FACTORS;

EID: 50549086519     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200807010-00009     Document Type: Article

References (35)

1. Appleby SB, Ristimaki A, Neilson K, Narko K, Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem J 1994; 302: 723-727.
2. Ermert L, Ermert M, Goppelt-Struebe M, Walmrath D, Grimminger F, Steudel W, et al. Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am J Respir Cell Mol Biol 1998; 18: 479-488.
3. Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, Clark AR. Regulation of cyclooxygenase 2 mRNA stability by the mitogen activated protein kinase p38 signaling cascade. Mol Cell Biol 2000; 20: 4265-4274.
4. Mitchell JA, Larkin S, Williams TJ. Cyclooxygenase-2: regulation and relevance in inflammation. Biochem Pharmacol 1995; 50: 1535-1542.
5. Lau CW, Yao XQ, Chen ZY, Ko WM, Huang Y. Cardiovascular actions of berberine. Cardiovasc Drug Rev 2001; 19: 234-244.
6. Kuo CL, Chi CW, Liu TY. Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells. In Vivo 2005; 19: 247-252.
7. Xu LH, Liu Y, He XH. Inhibitory effects of berberine on the activation and cell cycle progression of human peripheral lymphocytes. Cell Mol Immunol 2005; 2: 295-300.
8. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 1999; 66: 227-233.
9. Liang KW, Ting CT, Yin SC, Chen YT, Lin SJ, Liao JK, et al. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. Biochem Pharmacol 2006; 71: 806-817.
10. Souza RF, Shewmake K, Pearson S, Sarosi GA Jr, Feagins LA, Ramirez RD, et al. Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 2004; 287: 743-748.
11. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, et al. Berberine, a natural plant product, activates AMP activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006; 55: 2256-2264.
12. Zuo YF, Guo Y, Jiang X, Li FM, Wang QZ. Effects of berberine on a therosclerosis and plasma levels of lipid in a therosclerotic rabbits. Chin J Cerebrovasc Dis (Chin) 2006; 13: 204-207.
13. Zhao YN, Xin DM, Ding Y, Jing W, Wang W, Lei F, et al. Comparison of berberine between normal and febrile rats - pharmacokinetic study of antifebrile complex YL2000. Chin Pharmacol Bull (Chin) 2003; 10: 1170-1173.
14. Zhao YN, Ding Y, Wang RF, Xing DM, Cheng J, Du L. A new approach to investigate the pharmacokinetics of traditional chinese medicine YL2000. Am J Chin Med (Chin) 2004; 32: 921-929.
15. Suzuki T, Hashimoto S, Toyoda N, Nagai S, Yamazaki N, Dong HY, et al. Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE. Blood 2000; 96: 2584-2591.
16. Schmedtje JF Jr, Ji YS, Liu WL, Dubois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-kB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997; 272: 601-608.
17. Guo Y, Wang QZ, Tang BS, Zuo YF, Li FM, Jiang X, et al. Effects of aspirin on atherosclerosis and the COX-2 expression in atherosclerotic rabbits. Chin Med J 2006; 119: 1808-1814.
18. Belvisi MG, Saunders MA, Haddad el-B, Hirst SJ, Yacoub MH, Barnes PJ, et al. Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br J Pharmacol 1997; 120: 910-916.
19. Cipollone F, Rocca B, Patrono C. Cyclooxygenase-2 expression and inhibition in atherothrombosis. Arterioscler Thromb Vasc Biol 2004; 24: 246-255.
20. Smith LH, Boutaud O, Breyer M, Morrow JD, Oates JA, Vaughan DE. Cyclooxygenase-2-dependent prostacyclin formation is regulated by low density lipoprotein cholesterol in vitro. Arterioscler Thromb Vasc Biol 2002; 22: 983-988.
21. Nagata T, Kai H, Shibata R, Koga M, Yoshimura A, Imaizumi T. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells. Arterioscler Thromb Vasc Biol 2003; 23: 588-593.
22. Cornelissen J, Armstrong J, Holt CM. Mechanical stretch induces phosphorylation of p38-MAPK and apoptosis in human saphenous vein. Arterioscler Thromb Vasc Biol 2004; 24: 451-456.
23. Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 1996; 8: 205-215.
24. Yang CM, Chien CS, Hsiao LD, Lou SF, Wang CC. Interleukin-1-induced cyclooxygenase-2 expression is mediated through activation of p42/44 and p38 MAPKS, and NF-kB pathways in canine tracheal smooth muscle cells. Cell Signal 2002; 14: 899-911.
25. Moon Y, Pestka JJ. Vomitoxin-induced cyclooxygenase-2 gene expression in macrophages mediated by activation of ERK and p38 but not JNK mitogen activated protein kinases. Toxicol Sci 2002; 69: 373-382.
26. Luo SF, Wang CC, Chien CS, Hsiao LD, Yang CM. Induction of cyclooxygenase-2 by lipopolysaccharide in canine cultured tracheal smooth muscle cells: Involvement of p42/44 and p38 MAPK and NF-kB pathways. Cell Signal 2003; 15: 497-509.
27. Hecquet C, Lefevre G, Valtink M, Engelmann K, Mascarelli F. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation. Invest Ophthalmol Vis Sci 2002; 43: 3091-3098.
28. Dean JL, Brook M, Clark AR, Saklatvala J. p38 mitogen activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem 1999, 274:264-269.
29. Abidi P, Zhou Y, Jiang JD, Liu J. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscler Thromb Vasc Biol 2005; 25: 2170-2176.
30. Cho BJ, Im EK, Kwon JH, Lee KH, Shin HJ, Oh J, et al. Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells. Mol Cells 2005; 20: 429-434.
31. Kang BY, Chung SW, Cho D, Kim TS. Involvement of p38 mitogen activated protein kinase in the induction of interleukin-12 p40 production in mouse macrophages by Berberine, a benzodioxoloquinolizine alkaloid. Biochem Pharmacol 2002; 63: 1901-1910.
32. Lin SS, Chung JG, Lin JP, Chuang JY, Chang WC, Wu JY, et al. Berberine inhibits arylamine N-acetyltransferase activity and gene expression in mouse leukemia L 1210 cells. Phytomedicine 2005; 12: 351-358.
33. Sen P, Chakraborty PK, Raha S. Activation of p38MAPK by repetitive low-grade oxidative stress leads to pro-survival effects. Biochim Biophys Acta 2007; 1773: 367-374.
34. Subbaramaiah K, Hart JC, Norton L, Dannenberg AJ. Microtubule-interfering agents stimulate the transcription of cyclooxegenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen activated protein kinase pathways. J Biol Chem 2000; 275: 14838-14845.
35. Syrkina OL, Quinn DA, Jung W, Ouyang B, Hales CA. Inhibition of JNK activation prolongs survival after smoke inhalation from fires. Am J Physiol Lung Cell Mol Physiol 2007; 292: 984-991.